Reactive oxygen and nitrogen species in steatotic hepatocytes: A molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver

Antioxidants and Redox Signaling

Volumn 21, Issue 7, 2014, Pages 1119-1142

  Reiniers, Megan J ^a   Van Golen, Rowan F ^a   Van Gulik, Thomas M ^a   Heger, Michal ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYTOCHROME C; CYTOCHROME P450 2E1; FATTY ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2;

APOPTOSIS; CELL SURVIVAL; CYTOKINE RELEASE; CYTOTOXICITY; DISEASE ASSOCIATION; FATTY ACID OXIDATION; HUMAN; IMMUNE RESPONSE; INSULIN RESISTANCE; IRON OVERLOAD; LIPID LIVER LEVEL; LIPID OXIDATION; LIPID PEROXIDATION; LIVER CELL; LIVER ISCHEMIA; LIVER MITOCHONDRION; LIVER PERFUSION; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; UNFOLDED PROTEIN RESPONSE; ANIMAL; FATTY LIVER; METABOLISM; PATHOLOGY;

ANIMALS; FATTY LIVER; HEPATOCYTES; HUMANS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 84903988705     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5486     Document Type: Review

References (234)

1. Abdelmegeed MA, Banerjee A, Yoo SH, Jang S, Gonzalez FJ, and Song BJ. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced nonalcoholic steatohepatitis. J Hepatol 57: 860-866, 2012.
2. Afri M, Gottlieb HE, and Frimer AA. Superoxide organic chemistry within the liposomal bilayer, part II: a correlation between location and chemistry. Free Radic Biol Med 32: 605-618, 2002.
3. Aguirre V, Uchida T, Yenush L, Davis R, and White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000.
4. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma DW, and Heathcote JE. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 48: 300-307, 2008.
5. Alvarez B, Demicheli V, Durán R, Trujillo M, Cerveñansky C, Freeman BA, and Radi R. Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med 37: 813-822, 2004.
6. Alvarez B and Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25: 295-311, 2003.
7. Amersi F, Dulkanchainun T, Nelson SK, Farmer DG, Kato H, Zaky J, Melinek J, Shaw GD, Kupiec-Weglinski JW, and Horwitz LD. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation 71: 112-118, 2001.
8. Andriopoulos B, Hegedüsch S, Mangin J, Riedel HD, Hebling U, Wang J, Pantopoulos K, and Mueller S. Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron-responsive element network. J Biol Chem 282: 20301-20308, 2007.
9. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
10. Antosiewicz J, Ziolkowski W, Kaczor JJ, and Herman-Antosiewicz A. Tumor necrosis factor-alpha-induced reactive oxygen species formation is mediated by JNK1-dependent ferritin degradation and elevation of labile iron pool. Free Radic Biol Med 43: 265-270, 2007.
11. 2 gradients across biomembranes. FEBS Lett 475: 121-126, 2000.
12. Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, and De Menezes SL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med 32: 841-859, 2002.
13. Ängga°rd E. Nitric oxide: mediator, murderer, and medicine. Lancet 343: 1199-1206, 1994.
14. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51: 212-223, 2009.
15. Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, Tyagi S, Otterbein LE, Brouard S, Tobiasch E, Bach FH, Kupiec-Weglinski JW, and Soares MP. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17: 1724-1726, 2003.
16. Borutaite V and Brown GC. Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett 500: 114-118, 2001.
17. Brookes PS. Mitochondrial nitric oxide synthase. Mitochondrion 3: 187-204, 2004.
18. Brookes PS, Yoon Y, Robotham JL, Anders MW, and Sheu SS. Calcium, ATP, and ROS: a mitochondrial lovehate triangle. Am J Physiol Cell Physiol 287: C817-C833, 2004.
19. Brunt EM. Pathology of fatty liver disease. Mol Pathol 20: S40-S48, 2007.
20. Buerk DG, Lamkin-Kennard K, and Jaron D. Modeling the influence of superoxide dismutase on superoxide and nitric oxide interactions, including reversible inhibition of oxygen consumption. Free Radic Biol Med 34: 1488-1503, 2003.
21. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, and Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772, 2007.
22. Caraceni P, Ryu HS, van Thiel DH, and Borle AB. Source of oxygen free radicals produced by rat hepatocytes during postanoxic reoxygenation. Biochim Biophys Acta 1268: 249-254, 1995.
23. Carini R, Bellomo G, Dianzani MU, and Albano E. Evidence for a sodium-dependent calcium influx in isolated rat hepatocytes undergoing ATP depletion. Biochem Biophys Res Commun 202: 360-366, 1994.
24. Castello PR, David PS, McClure T, Crook Z, and Poyton RO. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab 3: 277-287, 2006.
25. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, and Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 37: 544-550, 2003.
26. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, and Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023, 2012.
27. Chavin KD, Yang SQ, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, and Huang CC. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274: 5692-5700, 1999.
28. Cheng G, Cao Z, Xu X, Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
29. Chen J, Schenker S, Frosto TA, and Henderson GI. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim Biophys Acta 1380: 336-344, 1998.
30. Chevallet M, Wagner E, Luche S, van Dorsselaer A, Leize-Wagner E, and Rabilloud T. Regeneration of peroxiredoxins during recovery after oxidative stress. J Biol Chem 278: 37146-37153, 2003.
31. Coddington JW, Hurst JK, and Lymar SV. Hydroxyl radical formation during peroxynitrous acid decomposition. J Am Chem Soc 121: 2438-2443, 1999.
32. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell, DA Jr. Role of tumor necrosis factoralpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85: 1936-1943, 1990.
33. Copple BL, Jaeschke H, and Klaassen CD. Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis 30: 195-204, 2010.
34. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, and Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282: 1659-1664, 1999.
35. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, and Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54: 133-144, 2011.
36. Cullinan SB and Diehl JA. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 279: 20108-20117, 2004.
37. Cuozzo JW and Kaiser CA. Competition between glutathione and protein thiols for disulphide-bond formation. Nat Cell Biol 1: 130-135, 1999.
38. Dallner G and Sindelar PJ. Regulation of ubiquinone metabolism. Free Radic Biol Med 29: 285-294, 2000.
39. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310, 2001.
40. Day CP and James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845, 1998.
41. dela Peña A, Leclercq IA, Williams J, and Farrell GC. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. J Hepatol 46: 304-313, 2007.
42. El-Badry AM, Jang JH, Elsherbiny A, Contaldo C, Tian Y, Raptis DA, Laczko E, Moritz W, Graf R, and Clavien PA. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2). J Hepatol 55: 1291-1299, 2011.
43. Ernster L and Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1271: 195-204, 1995.
44. Evans HM, Emerson OH, and Emerson GA. The isolation from wheat germ oil of an alcohol, αa-tocopherol, having the properties of vitamin E. J Biol Chem 113: 319-332, 1936.
45. Evans ZP, Ellett JD, Schmidt MG, Schnellmann RG, and Chavin KD. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem 283: 8573-8579, 2008.
46. Farrell GC, Wong VW, and Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol 10: 307-318, 2013.
47. Feldstein AE and Bailey SM. Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease. Antioxid Redox Signal 15: 421-424, 2011.
48. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, and Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437-443, 2003.
49. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65: 899-910, 1894.
50. Ferrington DA and Kapphahn RJ. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 578: 217-223, 2004.
51. Ford E, Hughes MN, and Wardman P. Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. Free Radic Biol Med 32: 1314-1323, 2002.
52. Ford ES, Giles WH, and Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 287: 356-359, 2002.
53. Forsmark-Andrée P, Lee L, Dallner G, and Ernster L. Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles. Free Radic Biol Med 22: 391-400, 1997.
54. Foster MW, McMahon TJ, and Stamler JS. S-nitrosylation in health and disease. Trends Mol Med 9: 160-168, 2003.
55. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669, 2008.
56. Garcia-Perez C, Roy SS, Naghdi S, Lin X, Davies E, and Hajnóczky G. Bid-induced mitochondrial membrane permeabilization waves propagated by local reactive oxygen species (ROS) signaling. Proc Natl Acad Sci U S A 109: 4497-4502, 2012.
57. García-Monzón C, Martín-Pérez E, Iacono OL, Fernández-Bermejo M, Majano PL, Apolinario A, Larrañaga E, and Moreno-Otero R. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33: 716-724, 2000.
58. García-Ruiz C, Colell A, Marí M, Morales A, Calvo M, Enrich C, and Fernández-Checa JC. Defective TNF-alphamediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111: 197-208, 2003.
59. Garrison WM. Reaction mechanisms in the radiolysis of peptides, polypeptides, and proteins. Chem Rev 87: 381-398, 1987.
60. Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS, and Heinecke JW. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A 98: 11961-11966, 2001.
61. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, and Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 90: 3491-3495, 1993.
62. Ghosh S and Karin M. Missing pieces in the NF-jB puzzle. Cell 109: S81-S96, 2002.
63. Giorgio M, Trinei M, Migliaccio E, and Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8: 722-728, 2007.
64. Gorsky LD, Koop DR, and Coon MJ. On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. J Biol Chem 259: 6812-6817, 1984.
65. Görlach A, Klappa P, and Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8: 1391-1418, 2006.
66. Graaf de W, Heger M, Spruijt O, Maas A, de Bruin K, Hoekstra R, Bennink RJ, and van Gulik TM. Quantitative assessment of liver function after ischemia-reperfusion injury and partial hepatectomy in rats. J Surg Res 172: 85-94, 2012.
67. Griendling KK and Fitz Gerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108: 1912-1916, 2003.
68. Gross E, Sevier CS, Heldman N, Vitu E, Bentzur M, Kaiser CA, Thorpe C, and Fass D. Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc Natl Acad Sci U S A 103: 299-304, 2006.
69. Gudz TI, Tserng KY, and Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cellpermeable ceramide. J Biol Chem 272: 24154-24158, 1997.
70. Gujral JS, Bucci TJ, Farhood A, and Jaeschke H. Mechanism of cell death during warm hepatic ischemiareperfusion in rats: apoptosis or necrosis? Hepatology 33: 397-405, 2001.
71. Guo Z, Shao L, Zheng L, Du Q, Li P, John B, and Geller DA. miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes. Proc Natl Acad Sci U S A 109: 5826-5831, 2012.
72. Halestrap AP, Woodfield KY, and Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272: 3346-5334, 1997.
73. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans 35: 1147-1150, 2007.
74. Halliwell B and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142: 231-255, 2004.
75. Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, and Kaplowitz N. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 283: 13565-13577, 2008.
76. Han D, Hanawa N, Saberi B, and Kaplowitz N. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic Biol Med 41: 627-639, 2006.
77. Han D, Hanawa N, Saberi B, and Kaplowitz N. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol 291: G1-G7, 2006.
78. Han D, Ybanez MD, Ahmadi S, Yeh K, and Kaplowitz N. Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal 11: 2245-2263, 2009.
79. Hardwick RN, Fisher CD, Canet MJ, Lake AD, and Cherrington NJ. Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 38: 2293-2301, 2010.
80. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, Yeldandi AV, Rao MS, and Reddy JK. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 274: 19228-19236, 1999.
81. Haynes CM, Titus EA, and Cooper AA. Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell 15: 767-776, 2004.
82. He S, Rehman H, Wright GL, and Zhong Z. Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts. Transplantation 89: 291-298, 2010.
83. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
84. Hochstein P and Utley H. Hydrogen peroxide detoxication by glutathione peroxidase and catalase in rat liver homogenates. Mol Pharmacol 4: 574-579, 1968.
85. Hotamisligil GS. Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
86. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917, 2010.
87. Houglum K, Filip M, Witztum JL, and Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 86: 1991-1998, 1990.
88. Houstis N, Rosen ED, and Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-948, 2006.
89. Huang X, Dai J, Fournier J, Ali AM, Zhang Q, and Frenkel K. Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. Free Radic Biol Med 32: 84-92, 2002.
90. Ignarro LJ. Biosynthesis and metabolism of endotheliumderived nitric oxide. Annu Rev Pharmacol Toxicol 30: 535-560, 1990.
91. Ip E, Farrell G, Hall P, Robertson G, and Leclercq I. Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39: 1286-1296, 2004.
92. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, and Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 65: 166-176, 2002.
93. Jaeschke H and Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125: 1246-1257, 2003.
94. Jaeschke H and Woolbright BL. Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev 26: 103-114, 2012.
95. Jump DB, Botolin D, Wang Y, Xu J, Christian B, and Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 135: 2503-2506, 2005.
96. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, and Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005.
97. Kakhlon O and Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 33: 1037-1046, 2002.
98. Kamata H, Honda S, Maeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFalphainduced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005.
99. Kawaguchi T, Noji S, Uda T, Nakashima Y, Takeyasu A, Kawai Y, Takagi H, Tohyama M, and Taniguchi N. A monoclonal antibody against COOH-terminal peptide of human liver manganese superoxide dismutase. J Biol Chem 264: 5762-5767, 1989.
100. Kettenhofen NJ and Wood MJ. Formation, reactivity, and detection of protein sulfenic acids. Chem Res Toxicol 23: 1633-1646, 2010.
101. 2 + -dependent mitochondrial formation of reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 302: G723-G731, 2012.
102. Kissner R, Nauser T, Bugnon P, Lye PG, and Koppenol WH. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem Res Toxicol 10: 1285-1292, 1997.
103. Kloek J, Marechal X, Roelofsen J, Houtkooper R, van Kuilenburg A, Kulik W, Bezemer R, Neviere R, van Gulik TM, and Heger M. Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion. Antioxid Redox Signal 17: 1109-1123, 2012.
104. Kono H and Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289, 2008.
105. Lambert AJ and Brand MD. Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J 382: 511-517, 2004.
106. Lazarow PB and De Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A 73: 2043-2046, 1976.
107. Leclercq IA. Pro-oxidants or anti-oxidant defenses? Which one to blame in non-alcoholic steatohepatitis pathogenesis? J Gastroenterol Hepatol 27: 1651-1653, 2012.
108. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, and Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105: 1067-1075, 2000.
109. Lee S, Gura KM, and Puder M. Omega-3 fatty acids and liver disease. Hepatology 45: 841-845, 2007.
110. Lemasters JJ, Theruvath TP, Zhong Z, and Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787: 1395-1401, 2009.
111. Levine RL, Moskovitz J, and Stadtman ER. Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 50: 301-307, 2000.
112. Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25: 3834-3847, 2006.
113. Lewerenz J and Maher P. Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem 284: 1106-1115, 2009.
114. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77: 517-544, 1997.
115. Lillie RD and Fullmer HMJA. Histopathologic Technic and Practical Histochemistry. New York: McGraw-Hill, 1976.
116. Li Q, Tomcik K, Zhang S, Puchowicz MA, and Zhang GF. Dietary regulation of catabolic disposal of 4-hydroxynonenal analogs in rat liver. Free Radic Biol Med 52: 1043-1053, 2012.
117. Li Y, Mouche S, Sajic T, Veyrat-Durebex C, Supale R, Pierroz D, Ferrari S, Negro F, Hasler U, Feraille E, Moll S, Meda P, Deffert C, Montet X, Krause KH, and Szanto I. Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity. Int J Obes (Lond) 36: 1503-1513, 2012.
118. Llacuna L, Fernández A, Montfort CV, Matías N, Martí- nez L, Caballero F, Rimola A, Elena M, Morales A, Fernández-Checa JC, and García-Ruiz C. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol 54: 1002-1010, 2011.
119. Llacuna L, Marí M, Garcia-Ruiz C, Fernandez-Checa JC, and Morales A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 44: 561-572, 2006.
120. Malaguarnera L, Madeddu R, Palio E, Arena N, and Malaguarnera M. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol 42: 585-591, 2005.
121. Mantena SK, King AL, Andringa KK, Eccleston HB, and Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol-and obesity-induced fatty liver diseases. Free Radic Biol Med 44: 1259-1272, 2008.
122. Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE, Kraus DW, Darley-Usmar VM, and Bailey SM. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417: 183-193, 2009.
123. Marí M, Colell A, Morales A, Caballero F, Moles A, Fernández A, Terrones O, Basañez G, Antonsson B, García-Ruiz C, and Fernández-Checa JC. Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-κB activation. Gastroenterology 134: 1507-1520, 2008.
124. Marí M, Morales A, Colell A, García-Ruiz C, and Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal 11: 2685-2700, 2009.
125. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 424: 83-95, 1999.
126. Maroz A, Anderson RF, Smith RA, and Murphy MP. Reactivity of ubiquinone and ubiquinol with superoxide and the hydroperoxyl radical: implications for in vivo antioxidant activity. Free Radic Biol Med 46: 105-109, 2009.
127. Marsman HA, Heger M, Kloek JJ, Nienhuis SL, ten Kate FJ, and van Gulik TM. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats. Digest Liver Dis 43: 984-990, 2011.
128. McCormack L, Dutkowski P, El-Badry AM, and Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol 54: 1055-1062, 2011.
129. McStay GP, Clarke SJ, and Halestrap AP. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 367: 541-548, 2002.
130. Medinas DB, Cerchiaro G, Trindade DF, and Augusto O. The carbonate radical and related oxidants derived from bicarbonate buffer. IUBMB Life 59: 255-262, 2007.
131. Meijer de VE, Kalish BT, Puder M, and Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97: 1331-1339, 2010.
132. Meli R, Mattace Raso G, Irace C, Simeoli R, di Pascale A, Paciello O, Pagano TB, Calignano A, Colonna A, and Santamaria R. High fat diet induces liver steatosis and early dysregulation of iron metabolism in rats. PLoS One 8: e66570, 2013.
133. Micheau O, Lens S, Gaide O, Alevizopoulos K, and Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305, 2001.
134. Micheau O and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190, 2003.
135. Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, and Gasbarrini G. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 98: 2335-2336, 2003.
136. Minicis de S, Seki E, Paik YH, Osterreicher CH, Kodama Y, Kluwe J, Torozzi L, Miyai K, Benedetti A, Schwabe RF, and Brenner DA. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology 52: 1420-1430, 2010.
137. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191: 144-148, 1961.
138. Montfort CV, Matias N, Fernandez A, Fucho R, de Rosa LCL, Martinez-Chantar ML, Mato JM, Machida K, Tsukamoto H, Murphy MP, Mansouri A, Kaplowitz N, Garcia-Ruiz C, and Fernandez-Checa JC. Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J Hepatol 57: 852-859, 2012.
139. Moschen AR, Kaser S, and Tilg H. Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol Metab 24: 537-545.
140. Mukhopadhyay P, Horváth B, Zsengellėr Z, Bátkai S, Cao Z, Kechrid M, Holovac E, Erdėlyi K, Tanchian G, Liaudet L, Stillman IE, Joseph J, Kalyanaraman B, and Pacher P. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med 53: 1123-1138, 2012.
141. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
142. Murphy MP, Echtay KS, Blaikie FH, Asin-Cayuela J, Cochemé HM, Green K, Buckingham JA, Taylor ER, Hurrell F, Hughes G, Miwa S, Cooper CE, Svistunenko DA, Smith RAJ, and Brand MD. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation. J Biol Chem 278: 48534-48545, 2003.
143. Nabeshima A, Yamada S, Guo X, Tanimoto A, Wang KY, Shimajiri S, Kimura S, Tasaki T, Noguchi H, Kitada S, Watanabe T, Fujii J, Kohno K, and Sasaguri Y. Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. Antioxid Redox Signal 19: 1983-1998, 2013.
144. Nair SP, Chacko V, Arnold C, and Diehl AM. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol 98: 466-470, 2003.
145. Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S, and Ezaki O. Mechanism for peroxisome proliferator activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem 277: 9562-9569, 2002.
146. Nappi AJ and Vass E. Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols. Biochim Biophys Acta 1336: 295-302, 1997.
147. Nardo B, Caraceni P, Pasini P, Domenicali M, Catena F, Cavallari G, Santoni B, Maiolini E, Grattagliano I, Vendemiale G, Trevisani F, Roda A, Bernardi M, and Cavallari A. Increased generation of reactive oxygen species in isolated rat fatty liver during postischemic reoxygenation. Transplantation 71: 1816-1820, 2001.
148. Nieminen AL, Byrne AM, Herman B, and Lemasters JJ. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol 272: C1286-C1294, 1997.
149. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 47: 469-484, 2009.
150. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, and Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A 99: 1259-1263, 2002.
151. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, and Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004.
152. Pagadala M, Kasumov T, McCullough AJ, Zein NN, and Kirwan JP. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab 23: 365-371, 2012.
153. Paugam-Burtz C, Janny S, de Lefosse D, Dahmani S, Dondero F, Mantz J, and Belghiti J. Prospective validation of the "fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249: 124-128, 2009.
154. Pessayre D. Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22: S20-S27, 2007.
155. 2 + -induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J Biol Chem 279: 53103-53108, 2004.
156. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, de Smaele E, Cong R, and Beaumont C. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542, 2004.
157. Pineda-Molina E, Klatt P, Vázquez J, Marina A, García de Lacoba M, Pérez-Sala D, and Lamas S. Glutathionylation of the p50 Subunit of NF-κB: a mechanism for redoxinduced inhibition of DNA binding. Biochemistry 40: 14134-14142, 2001.
158. Poli G, Schaur RJ, Siems WG, and Leonarduzzi G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 28: 569-631, 2007.
159. Pringle JH. V. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48: 541-549, 1908.
160. Pryor WA, Lightsey JW, and Church DF. Reaction of nitrogen dioxide with alkenes and polyunsaturated fatty acids: addition and hydrogen-abstraction mechanisms. J Am Chem Soc 104: 6685-6692, 1982.
161. Pryor W, Stanley J, and Blair E. Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandinlike endoperoxides. Lipids 11: 370-379, 1976.
162. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, and Sanyal AJ. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46: 1081-1090, 2007.
163. Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, and Sanyal AJ. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 134: 568-576, 2008.
164. Radi R, Cassina A, Hodara R, Quijano C, and Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33: 1451-1464, 2002.
165. Radi R, Denicola A, Alvarez B, Ferrer-Sueta G, and Rubbo H. The biological chemistry of peroxynitrite. In: Nitric Oxide, edited by Ignarro LJ. San Diego, CA: Academic Press, 2000, pp. 57-82.
166. Radi R, Peluffo G, Alvarez MN, Naviliat M, and Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30: 463-488, 2001.
167. Raedschelders K, Ansley DM, and Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133: 230-255, 2012.
168. Reddy JK and Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 21: 193-230, 2001.
169. Reddy JK and Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290: G852-G858, 2006.
170. Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, Geller DA, and Tsung A. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology 56: 2221-2230, 2012.
171. Reis A and Spickett CM. Chemistry of phospholipid oxidation. Biochim Biophys Acta 1818: 2374-2387, 2012.
172. Rensen SS, Bieghs V, Xanthoulea S, Arfianti E, Bakker JA, Shiri-Sverdlov R, Hofker MH, Greve JW, and Buurman WA. Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS One 7: e52411, 2012.
173. Rensen SS, Slaats Y, Nijhuis J, Jans A, Bieghs V, Driessen A, Malle E, Greve JW, and Buurman WA. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol 175: 1473-1482, 2009.
174. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, and Janssen-Heininger YM. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A 103: 13086-13091, 2006.
175. Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, and Testi R. GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J 14: 2047-2054, 2000.
176. Robertson G, Leclercq I, and Farrell GC. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281: G1135-G1139, 2001.
177. Rolo AP, Teodoro JS, and Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52: 59-69, 2012.
178. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK, and Davis RJ. Prevention of steatosis by hepatic JNK1. Cell Metab 10: 491-498, 2009.
179. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
180. Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T, and Nakano H. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22: 3898-3909, 2003.
181. Santos CXC, Tanaka LY, Wosniak J, Jr and Laurindo FRM. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 11: 2409-2427, 2009.
182. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, and Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192, 2001.
183. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, and Unalp A. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362: 1675-1685, 2010.
184. Schneider C, Tallman KA, Porter NA, and Brash AR. Two distinct pathways of formation of 4-hydroxynonenal. J Biol Chem 276: 20831-20838, 2001.
185. Seki E, Brenner DA, and Karin M. A Liver full of JNK: Signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143: 307-320, 2012.
186. Seki S, Kitada T, and Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res 33: 132-134, 2005.
187. Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD, Sastre J, Vendemiale G, and Altomare E. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 57: 957-965, 2008.
188. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, and Gladwin MT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204: 2089-2102, 2007.
189. -: role of nitrogen dioxide free radical. Proc Natl Acad Sci U S A 95: 12912-12917, 1998.
190. Spruss A, Kanuri G, Uebel K, Bischoff SC, and Bergheim I. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal 14: 2121-2135, 2011.
191. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, and Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50: 1094-1104, 2009.
192. Stadtman ER and Levine RL. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25: 207-218, 2003.
193. Surmeli NB, Litterman NK, Miller AF, and Groves JT. Peroxynitrite mediates active site tyrosine nitration in manganese superoxide dismutase. Evidence of a role for the carbonate radical anion. J Am Chem Soc 132: 17174-17185, 2010.
194. Szabó C, Ischiropoulos H, and Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662-680, 2007.
195. Tacchini T, Recalcati R, Bernelli-Zazzera BZ, and Cairo C. Induction of ferritin synthesis in ischemic-reperfused rat liver: analysis of the molecular mechanisms. Gastroenterology 113: 946-953, 1997.
196. Temkin V, Huang Q, Liu H, Osada H, and Pope RM. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol 26: 2215-2225, 2006.
197. Thariat J, Collin F, Marchetti C, Ahmed-Adrar NS, Vitrac H, Jore D, and Gardes-Albert M. Marked difference in cytochrome c oxidation mediated by HO(*) and/or O(2)(* -) free radicals in vitro. Biochimie 90: 1442-1451, 2008.
198. Tilg H and Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343: 1467-1476, 2000.
199. Tomita K. Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55: 415-424, 2006.
200. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, and Brenner DA. JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42: 850-859, 2005.
201. Uehara T, Xi Peng X, Bennett B, Satoh Y, Friedman G, Currin R, Brenner DA, and Lemasters J. c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78: 324-332, 2004.
202. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, and Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666, 2000.
203. Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, and Fargion S. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 138: 905-912, 2010.
204. Vandenabeele P, Galluzzi L, van den Berghe T, and Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700-714, 2010.
205. van Golen RF, van Gulik TM, and Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 52: 1382-1402, 2012.
206. van Golen RF, van Gulik TM, and Heger M. The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev 23: 69-84, 2012.
207. Ventura JJ, Cogswell P, Flavell RA, Baldwin AS, and Davis RJ. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 18: 2905-2915, 2004.
208. Veteläinen R, van Vliet A, Gouma DJ, and van Gulik TM. Steatosis as a risk factor in liver surgery. Ann Surg 245: 20-30, 2007.
209. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, Quiñones L, Varela N, Contreras J, Lazarte R, and Csendes A. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci 106: 261-268, 2004.
210. van der Vliet A, Eiserich JP, Kaur H, Cross CE, and Halliwell B. Nitrotyrosine as biomarker for reactive nitrogen species. In: Methods in Enzymology, Volume 269, edited by Packer L. San Diego, CA: Academic Press, 1996, pp. 175-184.
211. Vollmar B and Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89: 1269-1339, 2009.
212. von Bernhardi R and Eugenín J. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid Redox Signal 16: 974-1031, 2012.
213. Wang D, Wei Y, and Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147: 943-951, 2006.
214. Wang J and Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 434: 365-381, 2011.
215. Wardman P and Candeias LP. Fenton chemistry: an introduction. Radiat Res 145: 523-531, 1996.
216. Welch KD, Davis TZ, Eden MEV, and Aust SD. Deleterious iron-mediated oxidation of biomolecules. Free Radic Biol Med 32: 577-583, 2002.
217. Wellen KE and Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119, 2005.
218. Wiberg E, Holleman AF, and Wiberg N. (Eds). Holleman-Wiberg's Inorganic Chemistry. San Diego, CA: Academic Press, 2001, p. 1444.
219. Wong GH, Elwell JH, Oberley LW, and Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923-931, 1989.
220. Woo HA, Jeong W, Chang TS, Park KJ, Park SJ, Yang JS, and Rhee SG. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem 280: 3125-3128, 2005.
221. Wood ZA, Schroder E, Robin Harris J, and Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40, 2003.
222. Xia ZF, Horton JW, Zhao PY, Babcock EE, Sherry AD, and Malloy CR. Effects of ischemia on intracellular sodium and phosphates in the in vivo rat liver. J Appl Physiol 81: 1395-1403, 1996.
223. Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, Kim K, and Rhee SG. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277: 38029-38036, 2002.
224. Yang M, Camara AK, Wakim BT, Zhou Y, Gadicherla AK, Kwok WM, and Stowe DF. Tyrosine nitration of voltage-dependent anion channels in cardiac ischemiareperfusion: reduction by peroxynitrite scavenging. Biochim Biophys Acta 1817: 2049-2059, 2012.
225. Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanisoglu SY, Erdil A, Ates Y, Aslan M, Musabak U, Erbil MK, Karaeren N, and Dagalp K. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 100: 850-855, 2005.
226. Yin H, Xu L, and Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 111: 5944-5972, 2011.
227. Zangar RC, Davydov DR, and Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199: 316-331, 2004.
228. Zaouali MA, Bardag-Gorce F, Carbonell T, Oliva J, Pantazi E, Bejaoui M, Abdennebi HB, Rimola A, and Roselló-Catafau J. Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol 94: 352-359, 2013.
229. Zatloukal K, French SW, Stumptner C, Strnad P, Harada M, Toivola DM, Cadrin M, and Omary MB. From Mallory to Mallory-Denk bodies: what, how and why? Exp Cell Res 313: 2033-2049, 2007.
230. Zelko IN, Mariani TJ, and Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33: 337-349, 2002.
231. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, and Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332-336, 2009.
232. Zhang K and Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 454: 455-462, 2008.
233. Zhang W, Kudo H, Kawai K, Fujisaka S, Usui I, Sugiyama T, Tsukada K, Chen N, and Takahara T. Tumor necrosis factor-α accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. Biochem Biophys Res Commun 391: 1731-1736, 2010.
234. Zhao Y, Ding WX, Qian T, Watkins S, Lemasters JJ, and Yin XM. Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. Gastroenterology 125: 854-867, 2003.